The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The global Antiserum market was valued at US$ 1288.9 million in 2023 and is anticipated to reach US$ 2094.3 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
This report aims to provide a comprehensive presentation of the global market for Antiserum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiserum.
Report Scope
The Antiserum market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiserum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiserum companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Segment by Application
Clinical
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiserum companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The global Antiserum market was valued at US$ 1288.9 million in 2023 and is anticipated to reach US$ 2094.3 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
This report aims to provide a comprehensive presentation of the global market for Antiserum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiserum.
Report Scope
The Antiserum market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiserum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiserum companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Segment by Application
Clinical
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiserum companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2019-2030)
2.2 Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiserum Historic Market Size by Region (2019-2024)
2.2.3 Antiserum Forecasted Market Size by Region (2025-2030)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2019-2024)
3.1.2 Global Antiserum Revenue Market Share by Players (2019-2024)
3.2 Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2023
3.5 Antiserum Key Players Head office and Area Served
3.6 Key Players Antiserum Product Solution and Service
3.7 Date of Enter into Antiserum Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2019-2024)
4.2 Global Antiserum Forecasted Market Size by Type (2025-2030)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2019-2024)
5.2 Global Antiserum Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiserum Market Size (2019-2030)
6.2 North America Antiserum Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiserum Market Size by Country (2019-2024)
6.4 North America Antiserum Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2019-2030)
7.2 Europe Antiserum Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiserum Market Size by Country (2019-2024)
7.4 Europe Antiserum Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2019-2030)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiserum Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiserum Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiserum Market Size (2019-2030)
9.2 Latin America Antiserum Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiserum Market Size by Country (2019-2024)
9.4 Latin America Antiserum Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2019-2030)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiserum Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiserum Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Antiserum Introduction
11.1.4 BD Revenue in Antiserum Business (2019-2024)
11.1.5 BD Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Antiserum Introduction
11.2.4 Bio-Rad Revenue in Antiserum Business (2019-2024)
11.2.5 Bio-Rad Recent Development
11.3 Shanghai Serum Bio-Technology Co., Ltd.
11.3.1 Shanghai Serum Bio-Technology Co., Ltd. Company Detail
11.3.2 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
11.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Introduction
11.3.4 Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2019-2024)
11.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Development
11.4 China National Pharmaceutical Group
11.4.1 China National Pharmaceutical Group Company Detail
11.4.2 China National Pharmaceutical Group Business Overview
11.4.3 China National Pharmaceutical Group Antiserum Introduction
11.4.4 China National Pharmaceutical Group Revenue in Antiserum Business (2019-2024)
11.4.5 China National Pharmaceutical Group Recent Development
11.5 CSL
11.5.1 CSL Company Detail
11.5.2 CSL Business Overview
11.5.3 CSL Antiserum Introduction
11.5.4 CSL Revenue in Antiserum Business (2019-2024)
11.5.5 CSL Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Antiserum Introduction
11.6.4 Merck Revenue in Antiserum Business (2019-2024)
11.6.5 Merck Recent Development
11.7 BTG
11.7.1 BTG Company Detail
11.7.2 BTG Business Overview
11.7.3 BTG Antiserum Introduction
11.7.4 BTG Revenue in Antiserum Business (2019-2024)
11.7.5 BTG Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Antiserum Introduction
11.8.4 Pfizer Revenue in Antiserum Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Haffkine Bio-Pharmaceutical
11.9.1 Haffkine Bio-Pharmaceutical Company Detail
11.9.2 Haffkine Bio-Pharmaceutical Business Overview
11.9.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.9.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2019-2024)
11.9.5 Haffkine Bio-Pharmaceutical Recent Development
11.10 Vins Bioproducts
11.10.1 Vins Bioproducts Company Detail
11.10.2 Vins Bioproducts Business Overview
11.10.3 Vins Bioproducts Antiserum Introduction
11.10.4 Vins Bioproducts Revenue in Antiserum Business (2019-2024)
11.10.5 Vins Bioproducts Recent Development
11.11 Bharat Serums and Vaccines
11.11.1 Bharat Serums and Vaccines Company Detail
11.11.2 Bharat Serums and Vaccines Business Overview
11.11.3 Bharat Serums and Vaccines Antiserum Introduction
11.11.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2019-2024)
11.11.5 Bharat Serums and Vaccines Recent Development
11.12 SSI Diagnostica
11.12.1 SSI Diagnostica Company Detail
11.12.2 SSI Diagnostica Business Overview
11.12.3 SSI Diagnostica Antiserum Introduction
11.12.4 SSI Diagnostica Revenue in Antiserum Business (2019-2024)
11.12.5 SSI Diagnostica Recent Development
11.13 GD Animal Health
11.13.1 GD Animal Health Company Detail
11.13.2 GD Animal Health Business Overview
11.13.3 GD Animal Health Antiserum Introduction
11.13.4 GD Animal Health Revenue in Antiserum Business (2019-2024)
11.13.5 GD Animal Health Recent Development
11.14 MicroPharm
11.14.1 MicroPharm Company Detail
11.14.2 MicroPharm Business Overview
11.14.3 MicroPharm Antiserum Introduction
11.14.4 MicroPharm Revenue in Antiserum Business (2019-2024)
11.14.5 MicroPharm Recent Development
11.15 Peptide Institute Inc.
11.15.1 Peptide Institute Inc. Company Detail
11.15.2 Peptide Institute Inc. Business Overview
11.15.3 Peptide Institute Inc. Antiserum Introduction
11.15.4 Peptide Institute Inc. Revenue in Antiserum Business (2019-2024)
11.15.5 Peptide Institute Inc. Recent Development
11.16 Rare Disease Therapeutics
11.16.1 Rare Disease Therapeutics Company Detail
11.16.2 Rare Disease Therapeutics Business Overview
11.16.3 Rare Disease Therapeutics Antiserum Introduction
11.16.4 Rare Disease Therapeutics Revenue in Antiserum Business (2019-2024)
11.16.5 Rare Disease Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
